Patents by Inventor David Amaral

David Amaral has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11464882
    Abstract: A dry diffuser is disclosed which avoids safety and transport issues typical of liquid diffusers, candles and wax melts and provides systematic controlled diffusion of fragrance (or other active material) over relatively long periods with a programmable user interface.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: October 11, 2022
    Assignee: 1st Sense Technologies LLC
    Inventors: David Amaral, Robert Blaylock
  • Publication number: 20210213151
    Abstract: A dry diffuser is disclosed which avoids safety and transport issues typical of liquid diffusers, candles and wax melts and provides systematic controlled diffusion of fragrance (or other active material) over relatively long periods with a programmable user interface.
    Type: Application
    Filed: January 10, 2020
    Publication date: July 15, 2021
    Applicant: 1st Sense Technologies LLC
    Inventors: David AMARAL, Robert BLAYLOCK
  • Publication number: 20070003922
    Abstract: The present invention provides methods of identifying biomarkers indicative of the presence of a neurodevelopmental disorder, including an autism spectrum disorder, in an individual, using cytometry and mass spectrometry. The invention further provides methods of using the identified biomarkers to diagnose the presence of a neurodevelomental disorder, including an autism spectrum disorder.
    Type: Application
    Filed: May 5, 2006
    Publication date: January 4, 2007
    Applicant: The Regents of the University of California, Office of Technology Transfer
    Inventors: David Amaral, Blythe Corbett
  • Publication number: 20060292640
    Abstract: The present invention provides methods of identifying markers indicative of the risk of developing a neurodevelopmental disorder caused in part by antibody- or autoantibody-mediated damage of neural tissue, including autism spectrum disorder (ASD). The invention further provides methods of diagnosing whether an individual has a neurodevelopmental disorder, including an ASD, and methods for determining the risk that a mother's future offspring will develop an a neurodevelopmental disorder, including an ASD.
    Type: Application
    Filed: May 5, 2006
    Publication date: December 28, 2006
    Applicant: The Regents of the University of California Office of Technology Transfer
    Inventors: David Amaral, Judy Van de Water